エピソード

  • WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

    WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction
    2026/08/31
    At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce compulsive thinking and support addiction treatment.



    Chapters:

    00:00 Intro
    00:05 How did you get involved as a researcher in studying psychedelics?
    01:24 Some people say that psychedelics are one of the first new major innovations since the 70s in Psychiatry. How do you see that?
    03:07 Psychedelic treatment is a hybrid between talking therapy and psychopharmacological treatment. How is it different from traditional forms of treatment?
    05:53 What is the neuro biological mechanism that explains why psychedelics are so effective in treatment?
    10:16 Psychedelics don't work for everyone. Do we have any idea for whom they work and for whom they don't work?
    13:45 Do psychedelics have a potential to treat addiction?
    16:05 Clinical treatment has very strict rules and limitations. But people have been using psychedelics in other non-medical settings in groups, in the nature. Do you think that we can combine those methods with clinical treatment?
    17:53 Some people say that we move too fast. And, there is, risk of, backlash. How do you see that risk?
    18:55 You talked about retreats. As far as I know there are many retreats in the Netherlands. How are they regulated?
    20:48 What is the situation with MDMA treatment in the Netherlands?
    22:06 The costs of psychedelic treatment are very high. How can we make sure that they are accessible to less wealthy people as well?
    24:20 How do you see the role of harm reduction in the psychedelic field?
    26:09 How do you see the future of psychedelics? Will they be part of the mainstream medical care? And do they have room outside of the medical realm?

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    29 分
  • Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

    Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD
    2026/08/31
    What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researcher Sandeep Nayak about clinical trials, common therapeutic factors, and how the field can better understand the mechanisms behind psychedelic-assisted treatment.



    Chapters:

    00:00 Intro
    00:29 Could you introduce yourself?
    01:33 Is psychedelic therapy a major pharmacological innovation?
    02:12 Will psychedelic therapy become mainstream?
    03:06 What is evidence and what is hype?
    04:02 Where do psychedelics seem to work?
    05:15 How do you see the FDA decision on MDMA?
    07:15 What are the main methodological problems?
    08:59 How do you see the psychedelic renaissance now?
    11:02 Can researchers impose cultural values on participants?
    12:43 What research questions matter most now?
    15:05 Which theory of psychedelic action do you favor?
    17:33 Can microdosing be effective?
    19:01 Can the drug effect be separated from the experience?
    20:25 Can you share a memorable patient story?
    23:28 What is the potential for treating addiction?
    26:04 What other conditions could psychedelics help?
    27:19 Could group therapy reduce costs?
    28:24 How do you see political support from pseudoscientific voices?

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    34 分
  • NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

    NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world
    2026/08/31
    At ICPR 2024, we talked to anthropologist and author Nicolas Langlitz about the current hype around psychedelics, their place in medicine and culture, and why he sees them as holding the promise of moksha in the age of soma.



    Chapters: 00:00 Intro 00:05 Nicholas, can you talk about your professional background? 01:32 Some people say they are moving too fast. And there is an overhype of psychedelics. What do you think about that? 05:15 In your book, you write that psychedelics have the promise of moksha in the age of soma. 08:57 It seems nowadays the psychedelic movement has less ambitions, than in the 60s. So they don’t want to change the world, they just want to medicalize these substances. 11:17 Can we make psychedelics a standardized medical treatment? They come with so much spiritual and metaphysical baggage. 13:21 Unlike traditional antidepressants, in the case of psychedelics, it is very important in what environment you use drugs and in what mental states. Can you explain us the role of set and setting? 18:58 Some people would keep psychedelics under strict medical supervision. But do you think there is a room for psychedelics outside of the medical realm? 22:24 Is there no alternative to the biomedical model? 24:49 Timothy Leary has another idea about training people how to use psychedelics and giving out licenses such as driving licenses. That could be a secularized model to regulate these substances. What do you think?


    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    29 分
  • Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

    Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD
    2026/08/31
    Women make up more than half of the population, yet they remain significantly underrepresented in psychedelic research. At ICPR 2026, we spoke with neuroscientist Grace Blest-Hopley about the gender gap in psychedelic science, the importance of studying menstrual cycles, pregnancy, menopause, and women’s mental health, and how the field can become more inclusive and scientifically rigorous.



    Chapters

    00:00 Intro
    00:30 Could you introduce yourself?
    02:56 Why are military and psychedelic research male-dominated?
    06:08 How do gender differences appear in psychedelic trials?
    07:31 How do biology and hormones shape psychedelic experiences?
    11:18 Do trial designers understand these gender differences?
    12:45 Do women and men report psychedelic experiences differently?
    15:48 Could psychedelics help with postpartum depression or menopause?
    21:15 What are the key frontiers for future research?
    24:14 What is Hystelica and what are its goals?
    26:57 Do you meet resistance or openness in academia?
    29:44 Could future clinics focus on menopause or women’s health?


    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    32 分
  • MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

    MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes
    2026/05/26
    At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance of integration in psychedelic therapy.

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    16 分
  • PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

    PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot
    2026/04/20
    Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.

    Chapters:

    00:00 Intro
    00:39 Please Introduce PAREA
    06:59 Why Is Europe Lagging Behind the USA in Psychedelic Science?
    11:34 Which Psychedelic Substances Have the Greatest Potential to Become Medicines in the EU?
    14:00 Is There Potential in National Legislation, Such as in the Czech Republic?
    20:20 What Should Be Done About the Grey Areas of Psychedelic Treatment?
    26:42 How Can Professionals Be Trained in Psychedelic Treatment?

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    30 分
  • Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh

    Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh
    2026/04/17
    With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.

    Chapters:

    00:39 EU Drug Strategy Explained
    01:54 Real Impact on Member States?
    02:44 Civil Society’s Assessment
    05:26 Shift Toward Security?
    09:24 Cannabis Reform in the EU
    11:48 Eastern Europe & Security Focus
    15:41 Role of Civil Society
    19:35 Military vs Social Spending
    22:33 What Should the EU Do Next?

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    26 分
  • Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

    Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen
    2026/04/10
    As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.

    Chapters:
    00:00 Summary
    02:14 Introduction
    03:07 Who are you?
    07:42 Why does video activism matter?
    10:21 You’ve been in drug policy for years—how do you keep going?
    16:36 What keeps you motivated? What kind of drug policy do you want?
    22:46 Do you have a different drug policy position from the people you usually interview?
    27:54 You make media, write, and organize protests—what’s happening in Hungary?
    46:24 What’s it like coming to the CND and meeting people from more democratic countries?
    51:02 What do you think about the 69th UN Commission on Narcotic Drugs?
    54:06 Why does civil society need to be at the CND?

    Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/
    続きを読む 一部表示
    58 分